1474 POSTER A phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients

2005 ◽  
Vol 3 (2) ◽  
pp. 427
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Absolute Bioavailability ◽  
Vegf Receptor ◽  
Advanced Cancer Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Receptor Inhibitor

Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study

2005 ◽  
Vol 19 (1) ◽  
pp. 71-75 ◽  
Author(s):  
Jorge H Eisenchlas ◽  
Nicolás Garrigue ◽  
Marta Junin ◽  
Gustavo G De Simone
Keyword(s):  
Cancer Patients ◽  
Advanced Cancer ◽  
Low Dose ◽  
Advanced Cancer Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Refractory Emesis

A phase I, open-label study of the safety, tolerability and pharmacokinetics of lapatinib (GW572016) in combination with letrozole in cancer patients

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3001-3001 ◽  
Author(s):  
Q. Chu ◽  
L. Goldstein ◽  
N. Murray ◽  
E. Rowinsky ◽  
M. Cianfrocca ◽  
...  
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer

2010 ◽  
Vol 67 (4) ◽  
pp. 751-764 ◽  
Author(s):  
Anthony W. Tolcher ◽  
Leonard J. Appleman ◽  
Geoffrey I. Shapiro ◽  
Alain C. Mita ◽  
Frank Cihon ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Cardiovascular Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

PHASE I STUDY OF SYSTEMIC LYMPHOKINE (LCL-LK) ADMINISTRATION IN ADVANCED CANCER PATIENTS

1982 ◽  
pp. 633-639 ◽  
Author(s):  
Joaquim Gouveia ◽  
Patricia Ribaud ◽  
Antoine Goutner ◽  
Georges Mathé
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Advanced Cancer ◽  
Phase I Study ◽  
Advanced Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document